TransMedics Group, Inc. Deferred Tax Assets, Deferred Income
TransMedics Group, Inc. (TMDX) had Deferred Tax Assets, Deferred Income of $157.00 thousand as of 2019-12-28, per its 10-K filed 2020-03-17.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2020-03-17
- 2019-12-28: Deferred Tax Assets, Deferred Income $157.00K.
- 2018-12-29: Deferred Tax Assets, Deferred Income $227.00K.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2019-12-28 | $157.00K 10-K · filed 2020-03-17 |
| 2018-12-29 | $227.00K 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |